These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28162931)

  • 41. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
    Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
    Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceived barriers to medication adherence remain stable following solid organ transplantation.
    Danziger-Isakov L; Frazier TW; Worley S; Williams N; Shellmer D; Dharnidharka VR; Gupta NA; Ikle D; Shemesh E; Sweet SC;
    Pediatr Transplant; 2019 May; 23(3):e13361. PubMed ID: 31332928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.
    Boillot O; Seket B; Dumortier J; Pittau G; Boucaud C; Bouffard Y; Scoazec JY
    Liver Transpl; 2009 Nov; 15(11):1426-34. PubMed ID: 19877264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
    Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
    J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of Telephone-Based Health Coaching for Patients with Chronic Conditions: A Randomised Controlled Trial.
    Härter M; Dirmaier J; Dwinger S; Kriston L; Herbarth L; Siegmund-Schultze E; Bermejo I; Matschinger H; Heider D; König HH
    PLoS One; 2016; 11(9):e0161269. PubMed ID: 27632360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
    Fukudo M; Yano I; Masuda S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Liver Transpl; 2006 Feb; 12(2):292-300. PubMed ID: 16447186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study.
    Garaix F; Stern M; Lamy FX; Dubel L; Kamar N
    Ann Transplant; 2018 Aug; 23():561-571. PubMed ID: 30093607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of interventions in managing treatment adherence in adult heart transplant patients: a systematic review.
    Marcelino CA; Díaz LJ; da Cruz DM
    JBI Database System Rev Implement Rep; 2015 Sep; 13(9):279-308. PubMed ID: 26470673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early outcomes using alemtuzumab induction in lung transplantation.
    van Loenhout KC; Groves SC; Galazka M; Sherman B; Britt E; Garcia J; Griffith B; Iacono A
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):190-4. PubMed ID: 19939852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.
    Gastaca M; Valdivieso A; Bustamante J; Fernández JR; Ruiz P; Ventoso A; Testillano M; Palomares I; Salvador P; Prieto M; Montejo M; Suárez MJ; de Urbina JO
    Liver Transpl; 2016 Oct; 22(10):1391-400. PubMed ID: 27434676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial.
    Low JK; Manias E; Crawford K; Walker R; Mulley WR; Toussaint ND; Dooley M; Kennedy E; Smith CL; Nalder M; Yip D; Williams A
    Sci Rep; 2019 May; 9(1):7734. PubMed ID: 31118485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
    Chapman WC; Brown RS; Chavin KD; Sudan D; Koneru B; Junge G; Dong G; Patel D; Teperman L; Fung JJ
    Transplantation; 2017 Feb; 101(2):341-349. PubMed ID: 28121741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Smartphone Medication Adherence Saves Kidneys" for Kidney Transplantation Recipients: Protocol for a Randomized Controlled Trial.
    McGillicuddy J; Chandler J; Sox L; Mueller M; Nemeth L; Baliga P; Treiber F
    JMIR Res Protoc; 2019 Jun; 8(6):e13351. PubMed ID: 31228175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review.
    Low JK; Williams A; Manias E; Crawford K
    Nephrol Dial Transplant; 2015 May; 30(5):752-61. PubMed ID: 24950938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.